Stay updated on Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 tag appears on the page, indicating a version update; there is no visible change to study details or instructions.
    Difference
    0.3%
    Check dated 2026-02-11T14:22:18.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding status and NIH Clinical Center operations, and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T10:27:03.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a new 'Show glossary' option. Updated metadata labels (e.g., 'Last Update Submitted that Met QC Criteria', capitalization of 'No FEAR Act Data') and introduced a 'Revision: v3.4.0' tag.
    Difference
    0.1%
    Check dated 2026-01-28T06:24:09.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3, reflecting a routine version update with no changes to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:18:42.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T21:17:06.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed, which appears to be an internal version update with no impact on study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T10:53:18.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.